These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection. Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002 [TBL] [Abstract][Full Text] [Related]
3. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671 [TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031 [TBL] [Abstract][Full Text] [Related]
5. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240 [TBL] [Abstract][Full Text] [Related]
6. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654 [TBL] [Abstract][Full Text] [Related]
7. New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models. Lopes A; Bastiancich C; Bausart M; Ligot S; Lambricht L; Vanvarenberg K; Ucakar B; Gallez B; Préat V; Vandermeulen G J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795383 [TBL] [Abstract][Full Text] [Related]
8. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival. Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437 [TBL] [Abstract][Full Text] [Related]
9. Polysaccharide from Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530 [TBL] [Abstract][Full Text] [Related]
10. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation. David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689 [TBL] [Abstract][Full Text] [Related]
11. Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. Romagné F; André P; Spee P; Zahn S; Anfossi N; Gauthier L; Capanni M; Ruggeri L; Benson DM; Blaser BW; Della Chiesa M; Moretta A; Vivier E; Caligiuri MA; Velardi A; Wagtmann N Blood; 2009 Sep; 114(13):2667-77. PubMed ID: 19553639 [TBL] [Abstract][Full Text] [Related]
12. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer. Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495 [TBL] [Abstract][Full Text] [Related]
13. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma. Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237 [TBL] [Abstract][Full Text] [Related]
14. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia. Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313 [TBL] [Abstract][Full Text] [Related]
15. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression. Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126 [TBL] [Abstract][Full Text] [Related]
16. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Shilling HG; McQueen KL; Cheng NW; Shizuru JA; Negrin RS; Parham P Blood; 2003 May; 101(9):3730-40. PubMed ID: 12511415 [TBL] [Abstract][Full Text] [Related]
17. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand. Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313 [TBL] [Abstract][Full Text] [Related]
19. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. Yawata M; Yawata N; Draghi M; Little AM; Partheniou F; Parham P J Exp Med; 2006 Mar; 203(3):633-45. PubMed ID: 16533882 [TBL] [Abstract][Full Text] [Related]
20. Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors. Warren HS; Campbell AJ; Waldron JC; Lanier LL Int Immunol; 2001 Aug; 13(8):1043-52. PubMed ID: 11470774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]